Fifty-eight patients who had at least two episodes of gram-negative bacteremia were evaluated to define the epidemiology of recurrent bacteremia caused by these organisms. Thirty-two patients (55%) had single relapses, 16 (28%) had one reinfection, and 10 (17%) had more than one recurrence of bacteremia. Intravenous catheters were the most common probable source of bacteremia. Relapses occurred earlier after the initial episode than did reinfections (58 days vs. 292 days; P Å .002). The duration of antibiotic therapy for the first episode was shorter for patients with relapses than for those with reinfections (13.9 days vs. 17.5 days; P Å .046). Microorganisms causing recurrent bacteremic episodes were not unusually resistant to antimicrobial agents. Reinfections may be difficult to prevent because they are associated with the severity of the underlying illness, which may not improve. The frequency of relapses might be reduced by increasing the duration of antibiotic therapy and eliminating foci of infection.
Sepsis is the 13th leading cause of death in the United States,
We performed the current study to define the clinical and epidemiological features of recurrent gram-negative bacterand the age-adjusted mortality rate associated with sepsis has increased for 5 decades [1, 2] . About 500,000 cases of sepsis emia. We also sought to identify clinical characteristics discriminating relapses from reinfections. occur each year, one-fourth of which are associated with gramnegative bacteremia [3] . Gram-negative bacteremia is itself a serious infection, for which the estimated crude mortality is 20% -50% [4] . Moreover, 6% -10% of patients who have an Methods episode of gram-negative bacteremia will have at least one Patients and definitions. The database in the University recurrent episode [5, 6] ; thus, recurrent gram-negative bacterof Iowa Hospitals and Clinics' microbiology laboratory was emia is an important clinical problem [5 -11] .
reviewed to identify patients who had gram-negative bacterAlthough gram-negative sepsis has been studied intensively, emia between 1 January 1989 and 31 December 1993. All only a few studies have evaluated patients who have recurrent patients who had at least two bacteremic episodes caused by gram-negative bacteremia [5 -7, 12] . Most investigators have the same gram-negative species were identified and their isodefined recurrent bacteremia as that occurring after therapy for lates were evaluated microbiologically. An isolate was exa previous episode and after all signs and symptoms resolved cluded if the patient from whom it was recovered (1) was [5, 6] . Recently, Maslow et al. used molecular typing methods the only person who had recurrent bacteremia caused by that to differentiate relapsing bacteremia from reinfection [7] . They particular species or (2) had only one isolate that was viable defined relapsing bacteremia as that caused by the same strain, or typeable. independent of the time between episodes, and they defined A single bacteremic episode was defined as including all reinfection as any bacteremia caused by a different strain of positive blood cultures performed for one patient within a 7-the same species. Using these definitions, we found that 65% day period. Polymicrobial bacteremia was considered to be of recurrent gram-negative bacteremic episodes were relapses gram-negative if at least one gram-negative organism was isoand 35% were reinfections [13] . lated in the blood culture. Bacteremic episodes with onset ú48 hours after admission were considered to be nosocomial. A recurrence of bacteremia was defined as a second episode of bacteremia during the study period that was caused by the cedures to remove infected foci, and infectious disease consultations. Appropriate antimicrobial therapy was defined as administration of any antimicrobial agent to which the causative organism species isolated in blood cultures during the study period. Of these patients, 142 (13%) had a second bacteremic episode was susceptible in vitro. The length of antimicrobial therapy was defined as the time period from the first to the last day of caused by a gram-negative organism, 69 (49%) of whom had at least two episodes caused by the same gram-negative species. an appropriate antimicrobial regimen. Total antimicrobial days were calculated on the basis of the length of therapy with each Fifty-eight of the 69 patients met the inclusion criterion of having at least two isolates available for typing. appropriate antimicrobial agent (e.g., 7 days of gentamicin and 10 days of piperacillin would represent 17 total antimicrobial The median age of the patients was 39 years. Fifty-two percent of the patients had rapidly fatal underlying diseases days). Prophylactic use of antimicrobial agents was excluded.
Microbiological methods. Cultures, species identification, (table 1) , and 66% had malignancies. Numerous patients had bacteremic episodes before the first episodes that met the study susceptibility testing, and pulsed field gel electrophoresis were done as previously described [13, 17] .
criteria, many of which were caused by gram-positive organisms. In addition, 17 patients had bacteremia between the recurStatistical analysis. Differences between groups were compared by means of the Mantel-Haenzel x 2 test or the Fisher's rent episodes evaluated in this study. These intervening episodes of bacteremia were caused by gram-positive organisms exact test for categorical variables and the Mann-Whitney U test for continuous variables. Differences between paired varior different gram-negative organisms. Forty-eight of 58 patients had only two episodes of gramables were compared with the x 2 test with McNemar correction or the Wilcoxon matched-pairs signed-rank test if appropriate.
negative bacteremia caused by the same species: 32 had relapses and 16 had reinfections. Among these patients, Pseudomonas Alpha was set at 0.05, and tests were two-tailed. Statistical analyses were performed with SPSS for Windows (SPSS, aeruginosa caused 11 relapses and 5 reinfections, and Escherichia coli caused 10 relapses and 6 reinfections (table 2). Chicago).
Ten patients had more than two episodes (range, 3 -11) of gram-negative bacteremia caused by the same species (table 2) .
Results
Five of these patients had relapses and/or reinfections caused by more than one gram-negative species. E. coli was the most The microbiology laboratory's database included records from 3,350 patients, of whom 1,065 (32%) had gram-negative frequent pathogen among these patients. We did not include / 9c63$$mr11 02-24-99 11:17:13 cida UC: CID cal APACHE II scores at the time of admission before the first bacteremic episodes (table 3) . The APACHE II scores of patients in both groups increased from admission to the onset these 10 patients in the following analyses because we evaluof bacteremia, but the increase was significant only for patients ated the simplest cases (those involving only 1 relapse or 1 with one relapse (P Å .003, Wilcoxon matched-pairs signedreinfection).
rank test). Patients in both groups had higher APACHE II In the group of 48 patients with one recurrent episode of scores at the second admission than they did at the first admisbacteremia, patients who had one relapse and those who had sion, but the differences were statistically significant only for one reinfection were essentially indistinguishable. The folpatients who had single reinfections (P Å .045, Wilcoxon lowing variables did not discriminate between these groups: matched-pairs signed-rank test). age, sex, underlying diseases, other risk factors, prognosis, Most patients were symptomatic during bacteremia and also sources of bacteremia, and the proportion who had bacteremia met the criteria for sepsis [15] . However, nearly 20% of the before the first episode of bacteremia meeting the study critepatients with relapses did not meet the sepsis criteria during ria. However, the interval between the bacteremic episodes their second episode. The frequency of complications during was significantly shorter for patients who had relapses (58 the first bacteremic episode was nearly three times higher for days) than for patients who had reinfections (292 days) (figure patients with reinfections than for those with relapses (OR, 4.2; 95% CI, 0.81 -23.2). For patients who had reinfections, the 1 and table 3). Six (18.7%) of the 32 patients who had 1 NOTE. ARDS Å adult respiratory distress syndrome; DIC Å disseminated intravascular coagulation; MOF Å multiorgan failure.
* P Å .002 (Mann-Whitney U test). † Only adult patients are included in this analysis (patients with one relapse: n Å 26; patients with one reinfection: n Å 13).
‡ P Å .003 (Wilcoxon matched-pairs signed-rank test). § P Å .045 (Wilcoxon matched-pairs signed-rank test).
x Patients had no microbiologically confirmed source and had an intravascular catheter for ú24 hours.
frequency of complications during the first and second episodes Of 32 patients who had only 1 relapse, 7 relapsed during therapy. We excluded them from the analysis of therapy to was similar. In contrast, patients with relapses had significantly more complications during their second episode than during avoid introducing bias from obvious treatment failures. Among the remaining patients, the frequency of therapeutic measures their first episode (P õ .001, x 2 with McNemar correction).
/ 9c63$$mr11 02-24-99 11:17:13 cida UC: CID On the basis of molecular typing results, we determined that one relapse: n Å 17; patients with one reinfection: n Å 11).
3.8% of patients who had gram-negative bacteremia during the † P Å .05 (Mann-Whitney U test). ‡ P Å .03 (Mann-Whitney U test). study period had relapses and 3.3% had reinfections caused § P Å .03 (x 2 test).
by the same gram-negative species. We identified only three published studies that estimated the frequency of recurrent bacteremia [5 -7] . Mylotte and McDermott found that 9.8% of their prospective cohort had a second episode of gram-negative such as removal of central venous catheters or consultation with infectious disease experts was not significantly different bacteremia during the study period; 4.7% of the population had the same species isolated in both episodes [6] . In a prospective between patients who had relapses and those who had reinfections (table 4) . Furthermore, the number of appropriate antimicohort study by Capdevila et al., 5.3% of patients with gramnegative bacteremia had a second episode caused by a gramcrobial agents received by patients in both groups was essentially identical. However, compared with patients who had negative organism [5] . Because neither of these groups typed the isolates, they could not distinguish relapses from reinfecreinfections, patients who had relapses had a significantly shorter duration of therapy and had a lower total number of tions. Maslow et al. retrospectively identified 163 patients who had bacteremia caused by E. coli, of whom five had recurrent antimicrobial days (table 4) .
In the entire study population, 9 patients (15.5%; 7 patients episodes 1 -4 years later [7] . Four patients (i.e., 2.5% of the population) each had their own unique strain isolated in both who had 1 relapse and 2 patients who had several recurrences) had recurrent bacteremic episodes during appropriate antibiotic episodes and thus had relapses. Our study population and methods were different from those therapy. All nine bacteremic episodes were relapses, and central venous catheters were the probable source of the bacteremia of the previous studies. Unlike previous studies, we included children and patients with recurrent bacteremia during therapy for six patients, none of whom had their catheters removed during the first episode. With one exception, the organisms had [5, 6] . Furthermore, our follow-up period of 60 months was 12 months longer than that in the study of Capdevila et al. [5] . the same susceptibility patterns during both episodes. One P. aeruginosa strain became resistant to ticarcillin during the Despite these methodological differences, our data and those of the previous studies indicate that patients with recurrent 36 days between episodes, while the patient was treated with this agent.
bacteremic episodes often have malignancies or other severe underlying conditions [5, 7] . Only one of 58 patients was infected by a highly resistant strain. This P. aeruginosa strain was initially resistant to 18 of In our study, indwelling central venous catheters were the most common probable source of initial and recurrent episodes 22 antimicrobial agents against which it was tested. The organism became resistant to ciprofloxacin, an agent with which the of bacteremia. Previously, the urinary and respiratory tracts were the most common sources of gram-negative bacteremia patient had been treated, and subsequently caused a relapse.
Strains that caused relapses and those that caused reinfec- [6, 18 -20] . In addition, the frequency of malignancies and the proportion of patients with rapidly or ultimately fatal underlytions had similar antimicrobial susceptibility patterns. Among / 9c63$$mr11 02-24-99 11:17:13 cida UC: CID ing disease were higher in our study than previously reported. bacteremia, which includes all episodes of bacteremia occurring during appropriate treatment [8, 9] , are not as precise In contrast, the crude mortality in our study, 13.8%, was considerably lower than that reported in the literature (17% -49%) as our definition and do not help clinicians evaluate treatment options. [6, 12] . We do not know why our patients had a lower mortality rate. However, community-acquired bacteremia is associated Many of our patients died during the 5 years after their bacteremic episodes, but neither relapse nor reinfection increased the with lower mortality rates than is nosocomial bacteremia [18, 21] , and in our study the proportion of infections that were risk of death. The severity of the underlying disease, as assessed by the McCabe and Jackson criteria [14] , was the only variable community acquired (Ç60%) was higher than in the earlier studies (zero to 40%).
that predicted which patients were more likely to die. Mylotte and McDermott reported that 40% of recurrent bacThe primary difference in our study between patients who had one episode of relapsing bacteremia and those with one teremic episodes were caused by gentamicin-resistant organisms [6] . However, in our study, only two patients were infected episode of reinfection was the interval between the episodes, which was nearly six times longer for reinfections than for by gentamicin-resistant strains. Moreover, only one relapse was caused by a multiresistant strain, and only four (8.9%) of 45 relapses. During the long interval between infections, the patients' underlying diseases may have progressed, accounting strains that caused relapses became more resistant during therapy. Thus, in our patient population increasing antimicrobial for the significant increase in the median APACHE II score between the first and second admissions for patients with reinresistance was an infrequent cause of relapses.
In conclusion, the epidemiology of recurrent gram-negative fections. The frequency of complications during the initial and recurrent episodes of bacteremia was also different between bacteremia is complex. In our population, patient factors were more important than antimicrobial resistance. We frequently groups. Patients who had relapsing bacteremia had significantly fewer complications during their first episodes than during their cannot alter the patients' underlying conditions; therefore, we may not be able to prevent reinfections. However, we may be second episodes. They also had fewer complications during their first episodes than did patients who had one reinfection.
able to reduce the frequency of relapses by treating patients with appropriate antimicrobial agents for at least 14 days and In contrast, patients who had reinfections had a relatively high rate of complications during their first episodes.
by eliminating possible foci of infection, such as central venous catheters. We postulate that patients who had relapses may have had residual foci of infection or persistent reservoirs that were not
